Neoadjuvant pembrolizumab plus decitabine followed by standard neoadjuvant chemotherapy for locally advanced HER2-breast cancer (NCT02957968)

被引：1
|
作者：
Bear, Harry
Deng, Xiaoyan
Bandyopadhyay, Dipankar
Idowu, Michael
Kmieciak, Maciej
Williams, Monique
Archer, Giovanni
Gwaltney, Lindsey
Dillon, Patrick
Flora, Daniel
Stover, Daniel
Poklepovic, Andrew
Hackney, Mary
Ross, Masey
Vachhani, Hetal
Louie, Raphael
McGuire, Kandace
Grover, Amelia
Rahman, Tasnim
Hendrix, Amber
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO1-18-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO1-18-04
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Phase 3 study of neoadjuvant pembrolizumab or placebo plus chemotherapy, followed by adjuvant pembrolizumab or placebo plus endocrine therapy for early-stage high-risk ER+/ HER2-breast cancer: KEYNOTE-756
    Cardoso, Fatima
    O'Shaughnessy, Joyce
    McArthur, Heather
    Schmid, Peter
    Cortes, Javier
    Harbeck, Nadia
    Telli, Melinda
    Cescon, David
    Fasching, Peter A.
    Shao, Zhimin
    Loirat, Delphine
    Park, Yeon Hee
    Fernandez, Manuel Gonzalez
    Rubovszky, Gabor
    Im, Seock-Ah
    Hui, Rina
    Takano, Toshimi
    Andre, Fabrice
    Yasojima, Hiroyuki
    Liu, Zhenzhen
    Ding, Yu
    Jia, Liyi
    Karantza, Vassiliki
    Tryfonidis, Konstantinos
    Bardia, Aditya
    CANCER RESEARCH, 2024, 84 (09)
  • [42] Pathological complete response to neoadjuvant chemotherapy and outcomes in Her-2 negative locally advanced breast cancer
    Patel, A. B.
    Sharma, M.
    Joga, S.
    Goel, S.
    Doval, D. C.
    Talwar, V.
    Goyal, S.
    Batra, U.
    ANNALS OF ONCOLOGY, 2023, 34 : S1481 - S1482
  • [43] HER2 as a predictive factor for successful neoadjuvant anthracycline chemotherapy of locally advanced and early breast cancer
    Wang, Jiayu
    Xu, Binghe
    Yuan, Peng
    Li, Qing
    Zhang, Pin
    Cai, Ruigang
    Ma, Fei
    Fan, Ying
    Luo, Yang
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2014, 29 (03): : E187 - E192
  • [44] Neoadjuvant chemotherapy for locally advanced colonic cancer is not ready to be the standard of care
    Vimalachandran, Dale
    BRITISH JOURNAL OF SURGERY, 2023, 110 (12) : 1677 - 1678
  • [45] THE USEFULNESS OF SERUM VEGF LEVEL IN PREDICTING RESPONSE TO NEOADJUVANT CHEMOTHERAPY (NCT) IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER
    Wu, M.
    Midolo, P.
    Schneider-Kolsky, M.
    Hart, S.
    Susil, B.
    Stuckey, J.
    Fox, J.
    White, M.
    Andrew, S.
    Ganju, V.
    ANNALS OF ONCOLOGY, 2009, 20 : 46 - 46
  • [46] Neoadjuvant chemotherapy followed by chemoradiation in selected locally advanced squamous cervical cancer
    Fernando Cueva, Juan
    Martinez Lago, Nieves
    Vieito, Maria
    Gonzalez Patino, Ezequiel
    Curiel Garcia, Maria Teresa
    Salvador Garrido, Nuria
    Palacios Ozores, Patricia
    Candamio, Sonia
    Lopez Lopez, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] Critical Review of Neoadjuvant Chemotherapy Followed by Surgery for Locally Advanced Cervical Cancer
    Colombo, Nicoletta
    Peiretti, Michele
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 : S47 - S48
  • [48] Predictive score for response to neoadjuvant chemotherapy in early-stage HR + /HER2-breast cancer
    Coelho, Joao Queiros
    Lau, Beatriz
    Pichel, Rita
    Guerra, Laura
    Miranda, Hugo
    Romao, Raquel
    Sousa, Maria Joao
    Goncalves, Fernando
    Simoes, Joana
    Azevedo, Sergio Xavier
    Araujo, Antonio
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [49] Histopathologic changes following neoadjuvant chemotherapy in locally advanced breast cancer
    Sethi, D.
    Sen, R.
    Parshad, S.
    Khetarpal, S.
    Garg, M.
    Sen, J.
    INDIAN JOURNAL OF CANCER, 2013, 50 (01) : 58 - 64
  • [50] Neoadjuvant chemotherapy in locally-advanced breast cancer:: A preliminary report
    Baltali, E
    Firat, D
    Öncel, N
    Onat, DA
    Atahan, IL
    Büyükünal, E
    Çelik, I
    Aktan, G
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S35 - S35
12345